Uncategorized

Azura Ophthalmics Secures Grant to Evaluate AZR-MD-001 for Improved Vision Quality Related to Contact Lens Discomfort

by Business Wire • 2022/09/07 • 0 Comments

TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics secures funding from CUREator to advance AZR-MD-001 for improved vision quality tied to contact lens discomfort.

← Aura Biosciences to Present Phase 2 Safety Data Evaluating Suprachoroidal Administration of Belzupacap Sarotalocan (AU-011) in Patients with Choroidal Melanoma at the ESMO 2022 Congress

Visus Therapeutics to Present at the Baird 2022 Global Healthcare Conference →

Post navigation